BioCryst Pharmaceuticals, Inc.

BCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 May 19, 2026 PRIMARY DOCUMENT
144 May 18, 2026
4 May 15, 2026 PRIMARY DOCUMENT
144 May 13, 2026
SCHEDULE 13G May 12, 2026
10-Q May 6, 2026 10-Q
8-K May 6, 2026 FORM 8-K
8-K May 4, 2026 FORM 8-K
SCHEDULE 13G Apr 29, 2026
ARS Apr 23, 2026 ARS
DEFA14A Apr 23, 2026 DEFA14A
DEF 14A Apr 23, 2026 DEF 14A
4 Apr 7, 2026 PRIMARY DOCUMENT
3 Apr 7, 2026
SCHEDULE 13G/A Mar 26, 2026
4 Mar 24, 2026 PRIMARY DOCUMENT
144 Mar 20, 2026
4 Mar 18, 2026 PRIMARY DOCUMENT
144 Mar 16, 2026
4 Mar 3, 2026 PRIMARY DOCUMENT
4 Mar 3, 2026 PRIMARY DOCUMENT
4 Mar 3, 2026 PRIMARY DOCUMENT
4 Mar 3, 2026 PRIMARY DOCUMENT
← Newer Page 2 of 77 · 1920 filings Older →